Honest, jargon-free answers to the questions clients ask most often when briefing Lunar Labs.
About Lunar Labs
About Lunar Labs
Lunar Labs Ltd has applied for an MHRA licence and the application is currently under review. Our laboratory operations, methods and quality system are designed to meet MHRA and EU GMP expectations. We will publish licence details on this site as soon as authorisation is granted.
Lunar Labs Ltd is registered in England and Wales and operates from Unit D2, Cunard Road, Park Royal, London NW10 6PN.
Pharmaceuticals, consumer healthcare, nutraceuticals and dietary supplements, food and beverage, and veterinary medicine.
Sample Submission & Turnaround
Sample Submission & Turnaround
No — samples are received against an approved scope and a sample receipt form. This protects chain of custody and ensures the right test plan is in place before work begins.
Standard analytical batches typically return in 5–10 working days from sample receipt. Stability pulls and validated method development run on agreed protocol timelines. Urgent investigations can be expedited — discuss it on the brief.
Yes. Provide the import documentation, MSDS and any controlled-substance paperwork ahead of dispatch. We will send instructions on labelling, packaging and customs paperwork.
Methods & Reports
Methods & Reports
Reports are written to map cleanly onto MHRA and EU GMP expectations. Where applicable we reference ICH guidelines (Q1A stability, Q2 validation, Q6A specifications), USP / Ph. Eur. / BP monograph methods, and FSA/FSS guidance for food-sector samples.
Yes. Standard outputs include a Certificate of Analysis (CoA), method validation report, stability summary, or investigation report — formatted for inclusion in regulatory submissions.
Yes. We accept method transfers from other laboratories and can verify compendial methods. We will execute a documented transfer protocol with acceptance criteria agreed up front.
Phases & Programmes
Phases & Programmes
Yes. We support every phase from research and discovery through preclinical and clinical development to commercial manufacturing release. IMP testing is coordinated through our Clinical Development workstream.
Yes. We design protocols to ICH Q1A, manage controlled storage, perform pull-point analyses and issue summary reports with shelf-life recommendations per ICH Q1E.
Training & Consultancy
Training & Consultancy
Yes. Our Life Science Training & Consultancy arm covers GMP, method validation, stability programme design, regulatory dossier preparation, and bespoke client-site training.
Question we haven't answered?
Drop it in the contact form and we'll come back with a real, specific reply.
